The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...

The pharmaceutical industry is framing itself as a key partner for President Trump and HHS Secretary Robert F. Kennedy Jr. in ...

The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

PhRMA CEO Steve Ubl discusses, PBM reform, the "pill penalty" with the administration and advocating for pharmaceutical ...

The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...

Viewers of the Super Bowl may have seen an ad from one of the largest compounders in the United States, Hims & Hers, promoting… ...

Viewers of the Super Bowl may have seen an ad from one of the largest compounders in the United States, Hims & Hers, ...

Influential media outlets have been circulating research from a shadowy group without disclosing its links to the pharmaceutical industry.

The PhRMA Foundation announced the appointment to its Board of Directors of Dr. John C. Reed, MD, PhD, Executive Vice President of Innovative Medicine R&D at Johnson & Johnson (J&J), and Dr. Donatello ...

Given PhRMA’s stated support for pharmacy benefit manager transparency, the Senators argue it is only reasonable to have transparency across the pharmaceutical supply chain. The Senators ...

Legal challenges to Medicare’s price negotiation initiative introduced in the Inflation Reduction Act (IRA) continue to emerge, with pharmaceutical trade organisation PhRMA joining the fray ...